ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET
BAUDETTE, Minn., Feb. 07, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ:ANIP) today announced that the Company will release its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, prior to the market open.
Related news for (ANIP)
- ANI Pharmaceuticals Announces Presentation of New Preclinical Data
- ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
- ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
- ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model
- ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets